antiviral agent 5

Antiviral agent 5 is a crucial intermediate utilized in the development of antiviral agents that specifically target 3C and 3CL proteases, which includes the SARS-CoV-2 M pro enzyme.

Antiviralagent 59（compound 58）是一种广谱丝状病毒抑制剂，具有选择性和类药物特性。它对埃博拉病毒（EBOV）、苏丹病毒（SUDV）和马尔堡病毒（MARV）这些具有复制能力的病毒展示了低脱靶活性和有效的抑制作用。

Antiviralagent 55 (Compound 95) 是一种针对人类免疫缺陷病毒 1 和 2（HIV1和HIV2）的抑制剂，具有抗病毒活性。

Antiviralagent 56 (Compound 4) 表现出对HIV的有效抗病毒活性。

Antiviralagent 58 (Compound J1) 是口服抗病毒剂,对多种包膜病毒展现出广泛的抗病毒活性.这些病毒包括甲型流感病毒 (IAV)、呼吸道合胞病毒 (RSV)、严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2)、人冠状病毒OC43 (HCoV-OC43)、单纯疱疹病毒 1 型 (HSV-1) 和HSV-2.

Antiviralagent 57 (compound 81) 作为抗病毒化合物,对 ANO6 表现出超过 60% 的抑制效果,其有效浓度为 50 nM.

Antiviralagent 51 (compound a) 作为岩藻依聚糖，是一种有效的抗病毒剂。它与 DENV-2 RNA 依赖性 RNA 聚合酶 (RdRp) 产生相互作用。

Octyl gallate (Octyl 3,4,5-trihydroxybenzoate) 具有抗菌、抗氧化作用，有选择性和敏感性的荧光特性，广泛用作食品添加剂。它对 HSV-1，水泡性口炎病毒和脊髓灰质炎病毒有显著的抗病毒作用。

Retro-2 cycl 是一种抗病毒剂，是一种逆行运输抑制剂，抑制 JCPyV（IC50s：54 μM）和 HPV16 假病毒（IC50s：160 μM）。

(E)-5-(2-Bromovinyl)uracil (BVU) is a pyrimidine base and an inactive metabolite of the antiviral agents sorivudine and (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) that may be regenerated to BVDU in vivo. BVU irreversibly inactivates dihydropyrimidine dehydrogenase (DPD) in an NADPH-dependent manner. It enhances the efficacy of the chemotherapeutic agent and DPD substrate 5-fluorouracil in a P388 murine leukemia model when administered at a dose of 200 μmol kg, increasing survival time.

2-deoxy-D-Glucose-13C6is intended for use as an internal standard for the quantification of 2-deoxy-D-glucose by GC- or LC-MS. 2-deoxy-D-Glucose is a glucose antimetabolite and an inhibitor of glycolysis.1,2It inhibits hexokinase, the enzyme that converts glucose to glucose-6-phosphate, as well as phosphoglucose isomerase, the enzyme that converts glucose-6-phosphate to fructose-6-phosphate.32-deoxy-D-Glucose (16 mM) induces apoptosis in SK-BR-3 cells, as well as inhibits the growth of 143B osteosarcoma cells cultured under hypoxic conditions when used at a concentration of 2 mg ml.4,5In vivo, 2-deoxy-D-glucose (500 mg kg) reduces tumor growth in 143B osteosarcoma and MV522 non-small cell lung cancer mouse xenograft models when used alone or in combination with doxorubicin or paclitaxel .6 1.Kang, H.T., and Hwang, E.S.2-Deoxyglucose: An anticancer and antiviral therapeutic, but not any more a low glucose mimeticLife Sci.78(12)1392-1399(2006) 2.Aft, R.L., Zhang, F.W., and Gius, D.Evaluation of 2-deoxy-D-glucose as a chemotherapeutic agent: Mechanism of cell deathBr. J. Cancer87(7)805-812(2002) 3.Ralser, M., Wamelink, M.M., Struys, E.A., et al.A catabolic block does not sufficiently explain how 2-deoxy-D-glucose inhibits cell growthProc. Natl. Acad. Sci. USA105(46)17807-17811(2008) 4.Liu, H., Savaraj, N., Priebe, W., et al.Hypoxia increases tumor cell sensitivity to glycolytic inhibitors: A strategy for solid tumor therapy (Model C)Biochem. Pharmacol.64(12)1745-1751(2002) 5.Zhang, X.D., Deslandes, E., Villedieu, M., et al.Effect of 2-deoxy-D-glucose on various malignant cell lines in vitroAnticancer Res.26(5A)3561-3566(2006) 6.Maschek, G., Savaraj, N., Priebe, W., et al.2-deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivoCancer Res.64(1)31-34(2004)

(-)-5'-Noraristeromycin 是 一种抗病毒剂。(-)-5′-Noraristeromycin 也是 5'-noraristeromycin 的对映异构体，可抑制细胞内 HBV 复制和病毒粒子的产生。(-)-5'-Noraristeromycin 可以用于癌症的研究。

Antiviral agent 18 (Compound 5) 对鼠诺如病毒显示出良好的抗病毒活性。Antiviral agent 18 是一种抗感染剂，具有用于传染性和恶性疾病的研究潜力。

L-I-OddU, a potent and selective anti-Epstein-Barr virus (EBV) agent, is a L-5'-halo-dioxolane nucleoside analogue. It demonstrates antiviral activity by effectively suppressing replicative EBV DNA and viral protein synthesis [1] [2]. With an EC 50 value of 0.03 μM, L-I-OddU exhibits high potency against EBV while maintaining low cytotoxicity, as indicated by its CC 50 value of 1000 nM.

TMV-IN-5（化合物1a）是一种具有抗植物病毒 真菌活性的化合物。该物质能够通过与烟草花叶病毒（TMV）的CP结合，有效抑制病毒组装，有潜力用于农药开发。

BVDU 5′-Triphosphate 是带有 5′-Triphosphate 标记、针对 DNA 聚合酶的抗病毒药物。它对水痘-带状疱疹病毒（VZV）和单纯疱疹病毒 1 型（HSV-1）具有高度选择性，这种选择性归因于病毒编码的胸苷激酶对其进行特异性磷酸化的能力。

XSJ2-46，一种5'-氨基NI类似物，表现为有效的抗病毒药物，尤其针对Zika病毒。它通过抑制RNA依赖性RNA聚合酶（RdRp），展示出其活性，具有8.78 μM的IC50值。

EBOV-IN-5 (compound 14) 是针对埃博拉病毒 (Ebola virus，EBOV) 的抗病毒化合物，它通过阻止病毒糖蛋白 EBOV-GPcl 与必需的宿主受体 NPC1 的结合，来抑制病毒的融合和进入过程，从而抑制病毒感染。

EV-A71-IN-2 (compound 6c) 作为一种有效的抗EV-A71剂,其在MRC-5细胞和RD细胞测试中展示了出色的抑制效果,EC50值分别达到0.29 μM 和1.66 μM.该化合物主要应用于肠道病毒感染的研究领域.

DNA polymerase-IN-5 (compound 42) 是一种有效对抗 CMV 和 VZV 的广谱抗疱疹病毒化合物,其中对 CMV 的 IC50 为 6.6 μM,对 VZV 的 IC50 为 4.8 μM.

Nucleoside Derivatives - 5-Modified pyrimidine nucleosides; Azido-nucleosides; 2',3'-Dideoxy nucleosides; Drugs and Inhibitors; Antiviral agent